{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T05:05:53Z","timestamp":1770267953922,"version":"3.49.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,6,22]],"date-time":"2018-06-22T00:00:00Z","timestamp":1529625600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81370884"],"award-info":[{"award-number":["81370884"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["30900501"],"award-info":[{"award-number":["30900501"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81770807"],"award-info":[{"award-number":["81770807"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1007\/s12020-018-1652-y","type":"journal-article","created":{"date-parts":[[2018,6,22]],"date-time":"2018-06-22T06:36:40Z","timestamp":1529649400000},"page":"76-82","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Long-term follow-up of female prolactinoma patients at child-bearing age after transsphenoidal surgery"],"prefix":"10.1007","volume":"62","author":[{"given":"Na","family":"Yi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lijin","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoxia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuefei","family":"Shou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3744-5041","authenticated-orcid":false,"given":"Bin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,6,22]]},"reference":[{"key":"1652_CR1","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1001\/jama.2016.19699","volume":"317","author":"ME Molitch","year":"2017","unstructured":"M.E. Molitch, Diagnosis and treatment of pituitary adenomas: A review. JAMA 317, 516\u2013524 (2017)","journal-title":"JAMA"},{"key":"1652_CR2","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","volume":"131","author":"DN Louis","year":"2016","unstructured":"D.N. Louis, A. Perry, G. Reifenberger, A. von Deimling, D. Figarella-Branger, W.K. Cavenee et al., The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol. 131, 803\u2013820 (2016)","journal-title":"Acta Neuropathol."},{"key":"1652_CR3","doi-asserted-by":"publisher","first-page":"g5390","DOI":"10.1136\/bmj.g5390","volume":"349","author":"A Rogers","year":"2014","unstructured":"A. Rogers, N. Karavitaki, J.A. Wass, Diagnosis and management of prolactinomas and non-functioning pituitary adenomas. BMJ 349, g5390 (2014)","journal-title":"BMJ"},{"key":"1652_CR4","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1210\/jc.2010-1692","volume":"96","author":"S Melmed","year":"2011","unstructured":"S. Melmed, F.F. Casanueva, A.R. Hoffman, D.L. Kleinberg, V.M. Montori, J.A. Schlechte et al., Endocrine Society. Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline. J. Clin. Endocrinol. Metab. 96, 273\u2013288 (2011)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1652_CR5","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s11060-013-1270-8","volume":"117","author":"ME Molitch","year":"2014","unstructured":"M.E. Molitch, Management of medically refractory prolactinoma. J. Neurooncol. 117, 421\u2013428 (2014)","journal-title":"J. Neurooncol."},{"key":"1652_CR6","doi-asserted-by":"publisher","first-page":"307","DOI":"10.3171\/jns.2002.97.2.0307","volume":"97","author":"AP Amar","year":"2002","unstructured":"A.P. Amar, W.T. Couldwell, J.C. Chen, M.H. Weiss, Predictive value of serum prolactin levels measured immediately after transsphenoidal surgery. J. Neurosurg. 97, 307\u2013314 (2002)","journal-title":"J. Neurosurg."},{"key":"1652_CR7","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1530\/eje.0.1400043","volume":"140","author":"HE Turner","year":"1999","unstructured":"H.E. Turner, C.B. Adams, J.A. Wass, Trans-sphenoidal surgery for microprolactinoma: an acceptable alternative to dopamine agonists? Eur. J. Endocrinol. 140, 43\u201347 (1999)","journal-title":"Eur. J. Endocrinol."},{"key":"1652_CR8","first-page":"610","volume":"33","author":"E Knosp","year":"1993","unstructured":"E. Knosp, E. Steiner, K. Kitz, C. Matula, Pituitary adenomas with invasion of the cavernous sinus space: a magnetic resonance imaging classification compared with surgical findings. Neurosurgery 33, 610\u2013617 (1993)","journal-title":"Neurosurgery"},{"key":"1652_CR9","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1530\/EJE-07-0248","volume":"158","author":"J Kreutzer","year":"2008","unstructured":"J. Kreutzer, R. Buslei, H. Wallaschofski, B. Hofmann, C. Nimsky, R. Fahlbusch et al., Operative treatment of prolactinomas: indications and results in a current consecutive series of 212 patients. Eur. J. Endocrinol. 158, 11\u201318 (2008)","journal-title":"Eur. J. Endocrinol."},{"key":"1652_CR10","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1097\/00006123-199902000-00006","volume":"44","author":"JB Tyrrell","year":"1999","unstructured":"J.B. Tyrrell, K.R. Lamborn, L.T. Hannegan, C.B. Applebury, C.B. Wilson, Transsphenoidal microsurgical therapy of prolactinomas: initial outcomes and long-term results. Neurosurgery 44, 254\u2013261 (1999)","journal-title":"Neurosurgery"},{"key":"1652_CR11","doi-asserted-by":"publisher","first-page":"857","DOI":"10.2169\/internalmedicine.40.857","volume":"40","author":"T Sabuncu","year":"2001","unstructured":"T. Sabuncu, E. Arikan, E. Tasan, H. Hatemi, Comparison of the effects of cabergoline and bromocriptine on prolactin levels in hyperprolactinemic patients. Intern. Med. 40, 857\u2013861 (2001)","journal-title":"Intern. Med."},{"key":"1652_CR12","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s12020-015-0727-2","volume":"51","author":"S Noronha","year":"2016","unstructured":"S. Noronha, V. Stokes, N. Karavitaki, A. Grossman, Treating prolactinomas with dopamine agonists: always worth the gamble? Endocrine 51, 205\u2013210 (2016)","journal-title":"Endocrine"},{"key":"1652_CR13","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1530\/EJE-11-1000","volume":"166","author":"V Primeau","year":"2012","unstructured":"V. Primeau, C. Raftopoulos, D. Maiter, Outcomes of transsphenoidal surgery in prolactinomas: improvement of hormonal control in dopamine agonist-resistant patients. Eur. J. Endocrinol. 166, 779\u2013786 (2012)","journal-title":"Eur. J. Endocrinol."},{"key":"1652_CR14","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1016\/j.jocn.2015.06.001","volume":"22","author":"TR Smith","year":"2015","unstructured":"T.R. Smith, M.M. Hulou, K.T. Huang, A. Gokoglu, D.J. Cote, W.W. Woodmansee et al., Current indications for the surgical treatment of prolactinomas. J. Clin. Neurosci. 22, 1785\u20131791 (2015)","journal-title":"J. Clin. Neurosci."},{"key":"1652_CR15","doi-asserted-by":"publisher","first-page":"3709","DOI":"10.1210\/jc.2015-2453","volume":"101","author":"F Alexander","year":"2016","unstructured":"F. Alexander, C. Paweena, N. Joshipura et al., Dopamine agonists can reduce cystic prolactinomas. J. Clin. Endocrinol. Metab. 101, 3709\u20133715 (2016)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1652_CR16","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s11102-016-0766-6","volume":"20","author":"T Ogiwara","year":"2017","unstructured":"T. Ogiwara, T. Horiuchi, A. Nagm, T. Goto, K. Hongo, Significance of surgical management for cystic prolactinoma. Pituitary 20, 225\u2013230 (2017)","journal-title":"Pituitary"},{"key":"1652_CR17","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1210\/er.2005-9998","volume":"27","author":"MP Gillam","year":"2006","unstructured":"M.P. Gillam, M.E. Molitch, G. Lombardi, A. Colao, Advances in the treatment of prolactinomas. Endocr. Rev. 27, 485\u2013534 (2006)","journal-title":"Endocr. Rev."},{"key":"1652_CR18","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1530\/eje.0.1400043","volume":"140","author":"HE Turner","year":"1999","unstructured":"H.E. Turner, C.B. Adams, J.A. Wass, Trans-sphenoidal surgery for microprolactinoma: an acceptable alternative to dopamine agonists? Eur. J. Endocrinol. 140, 43\u201347 (1999)","journal-title":"Eur. J. Endocrinol."},{"key":"1652_CR19","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.ando.2007.03.011","volume":"68","author":"M Jan","year":"2007","unstructured":"M. Jan, H. Dufour, T. Brue, P. Jaquet, Prolactinoma surgery. Ann. Endocrinol. (Paris) 68, 118\u2013119 (2007)","journal-title":"Ann. Endocrinol. (Paris)"},{"key":"1652_CR20","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1007\/s11102-011-0368-2","volume":"15","author":"M Berker","year":"2012","unstructured":"M. Berker, D.B. Hazer, T. Y\u00fccel, A. G\u00fcrlek, A. Cila, M. Aldur, M. Onerci, Complications of endoscopic surgery of the pituitary adenomas: analysis of 570 patients and review of the literature. Pituitary 15, 288\u2013300 (2012)","journal-title":"Pituitary"},{"key":"1652_CR21","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1227\/01.neu.0000325862.83961.12","volume":"62","author":"AR Dehdashti","year":"2008","unstructured":"A.R. Dehdashti, A. Ganna, K. Karabatsou, F. Gentili, Pure endoscopic endonasal approach for pituitary adenomas: early surgical results in 200 patients and comparison with previous microsurgical series. Neurosurgery 62, 1006\u20131017 (2008)","journal-title":"Neurosurgery"},{"key":"1652_CR22","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1007\/s11102-009-0195-x","volume":"13","author":"JA Gondim","year":"2010","unstructured":"J.A. Gondim, M. Schops, J.P. de Almeida, L.A. de Albuquerque, E. Gomes, T. Ferraz, F.A. Barroso, Endoscopic endonasal transsphenoidal surgery: surgical results of 228 pituitary adenomas treated in a pituitary center. Pituitary 13, 68\u201377 (2010)","journal-title":"Pituitary"},{"key":"1652_CR23","doi-asserted-by":"publisher","first-page":"224","DOI":"10.3325\/cmj.2012.53.224","volume":"53","author":"A Mari\u0107","year":"2012","unstructured":"A. Mari\u0107, I. Kruljac, V. \u010cerina, H.I. Pe\u0107ina, P. \u0160ulenti\u0107, M. Vrkljan, Endocrinological outcomes of pure endoscopic transsphenoidal surgery: a Croatian Referral Pituitary Center experience. Croat. Med. J. 53, 224\u2013233 (2012)","journal-title":"Croat. Med. J."},{"key":"1652_CR24","doi-asserted-by":"publisher","first-page":"R89","DOI":"10.1530\/EJE-16-0087","volume":"175","author":"M Tampourlou","year":"2016","unstructured":"M. Tampourlou, R. Trifanescu, A. Paluzzi, S.K. Ahmed, N. Karavitaki, Therapy of endocrine disease: Surgery in microprolactinomas: effectiveness and risks based on contemporary literature. Eur. J. Endocrinol. 175, R89\u201396 (2016)","journal-title":"Eur. J. Endocrinol."},{"key":"1652_CR25","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s12020-016-1115-2","volume":"55","author":"L Andereggen","year":"2017","unstructured":"L. Andereggen, J. Frey, R.H. Andres, M. El-Koussy, J. Beck, R.W. Seiler, E. Christ, 10-year follow-up study comparing primary medical vs. surgical therapy in women with prolactinomas. Endocrine 55, 223\u2013230 (2017)","journal-title":"Endocrine"},{"key":"1652_CR26","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1016\/j.clineuro.2013.02.016","volume":"115","author":"H Ikeda","year":"2013","unstructured":"H. Ikeda, K. Watanabe, T. Tominaga, T. Yoshimoto, Transsphenoidal microsurgical results of female patients with prolactinomas. Clin. Neurol. Neurosurg. 115, 1621\u20131625 (2013)","journal-title":"Clin. Neurol. Neurosurg."},{"key":"1652_CR27","first-page":"21557","volume":"8","author":"Z Yan","year":"2015","unstructured":"Z. Yan, Y. Wang, X. Shou, J. Su, L. Lang, Effect of transsphenoidal surgery and standard care on fertility related indicators of patients with prolactinomas during child-bearing period. Int. J. Clin. Exp. Med. 8, 21557\u201321564 (2015)","journal-title":"Int. J. Clin. Exp. Med."},{"key":"1652_CR28","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1007\/s11102-010-0283-y","volume":"14","author":"M Babey","year":"2011","unstructured":"M. Babey, R. Sahli, I. Vajtai, R.H. Andres, R.W. Seiler, Pituitary surgery for small prolactinomas as an alternative to treatment with dopamine agonists. Pituitary 14, 222\u2013230 (2011)","journal-title":"Pituitary"},{"key":"1652_CR29","doi-asserted-by":"publisher","first-page":"56","DOI":"10.3109\/02688697.2012.714817","volume":"27","author":"FL Vale","year":"2013","unstructured":"F.L. Vale, A.R. Deukmedjian, S. Hann, V. Shah, A.D. Morrison, Medically treated prolactin-secreting pituitary adenomas: when should we operate? Br. J. Neurosurg. 27, 56\u201362 (2013)","journal-title":"Br. J. Neurosurg."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12020-018-1652-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-018-1652-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-018-1652-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,19]],"date-time":"2019-09-19T23:47:29Z","timestamp":1568936849000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12020-018-1652-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,22]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["1652"],"URL":"https:\/\/doi.org\/10.1007\/s12020-018-1652-y","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,22]]},"assertion":[{"value":"30 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}